RegASK
AI-Driven Regulatory Intelligence for Life Sciences and CPG Excellence.
Est 2018|Valuation $24.5M|Raised $21.9M
AI-Driven Regulatory Intelligence for Life Sciences and CPG Excellence.
Published Sep 2, 2026
Vendor announcements reference future-facing capabilities and interoperability with emerging standards. These are forward-looking statements; evaluators should confirm availability, timelines, and enterprise readiness.
No explicit public documentation was found on scale limits (e.g., maximum documents, alert volumes, or API quotas). Evaluators should validate these during procurement.
The vendor publishes case studies with quantified outcomes. Two examples surfaced on the vendor site.
The vendor website includes customer quotes such as:
These quotes indicate perceived value (speed, flexibility, global expertise) but are vendor-published and should be corroborated with independent references.
Glassdoor contains both negative and positive employee reviews.
Interpretation: employee reviews do not directly confirm product quality but may correlate with operational risks affecting support consistency and account management.
In the absence of broad independent product reviews, churn reasons are speculative. Plausible reasons include:
Vendor-claimed outcomes:
Critical evaluation: these metrics are vendor-published and do not include public methodology. Terms such as compliance claims require definition of scope (which trials, which regulations, audit criteria, and timeframe) to be independently verifiable.
Based on the vendor’s pricing model and security posture claims, likely fits include:
Industries aligned with vendor positioning and examples:
Get a comprehensive analysis of RegASK including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →RegASK may be less suitable when:
Transparent pricing and self-serve trials are required
Independently validated AI performance evidence is required
The primary need is broad EHS compliance rather than product RA/product compliance workflows
The regulatory scope is mainly U.S. legal/regulatory change management with per-user governance and citation requirements
Low tolerance for vendor organizational instability exists
RegASK appears to have limited coverage on mainstream B2B review platforms (e.g., G2/Capterra pages were not easily discoverable in the research performed here). As a result, independent end-user feedback is harder to validate from review ecosystems.
This report includes:
Vendor-claimed outcomes:
Critical evaluation: these figures are directional productivity indicators but lack published measurement methodology (baseline process, measurement period, what constitutes "handling"). Evaluators should request detailed before/after artifacts and measurement definitions.
Recommendation for evaluators: request customer references and, where possible, obtain documented measurement definitions and evidence for claimed outcomes.
RegASK is a B2B regulatory intelligence and workflow platform intended to help organizations monitor regulatory changes, generate impact assessments, and coordinate regulatory work across global markets—primarily for Life Sciences and Consumer Products/CPG teams. The platform combines:
RegASK’s GenAI capability, referred to by the vendor as RegGenius, is described as a conversational assistant that answers regulatory questions, summarizes and translates documents, and converts alerts into tailored impact analyses.
Positioning described by the vendor: vertical specialization for regulatory teams in regulated industries rather than broad GRC.
Primary segments referenced by the vendor and by product examples:
The product emphasizes global coverage and local expertise and is aimed at organizations operating across multiple jurisdictions where manual monitoring can be resource intensive.